Heteroaryl derivatives
US9133185B2 · kind B2 · utility
3Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2014 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Dec 4, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2202/064
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.